Accel Wealth Management Viatris Inc Transaction History

Accel Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$9.2 - $12.26 $358 - $478	-39 Reduced 20.21%	154 $1,000
Q4 2022 Jan 26, 2023	SELL	$8.72 - $11.56 $2,432 - $3,225	-279 Reduced 59.11%	193 $0
Q3 2022 Oct 12, 2022	BUY	$8.48 - $11.13 $42 - $55	5 Added 1.07%	472 $4,000
Q2 2022 Aug 03, 2022	SELL	$9.95 - $12.27 $994 - $1,227	-100 Reduced 17.64%	467 $5,000
Q1 2022 Apr 29, 2022	BUY	$9.81 - $15.4 $804 - $1,262	82 Added 16.91%	567 $6,000
Q4 2021 Jan 18, 2022	SELL	$12.09 - $14.68 $1,329 - $1,614	-110 Reduced 18.49%	485 $7,000
Q3 2021 Nov 04, 2021	SELL	$13.25 - $15.13 $2,848 - $3,252	-215 Reduced 26.54%	595 $8,000
Q2 2021 Aug 03, 2021	SELL	$12.97 - $16.15 $22,606 - $28,149	-1,743 Reduced 68.27%	810 $12,000
Q1 2021 May 10, 2021	BUY	$13.59 - $18.54 $15,859 - $21,636	1,167 Added 84.2%	2,553 $36,000
Q4 2020 Jan 27, 2021	BUY	$14.3 - $18.74 $19,819 - $25,973	1,386 New	1,386 $26,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.